...
首页> 外文期刊>Craniomaxillofacial Trauma & Reconstruction >Addressing the Opioid Epidemic: Impact of Opioid Prescribing Protocol at the University of Minnesota School of Dentistry
【24h】

Addressing the Opioid Epidemic: Impact of Opioid Prescribing Protocol at the University of Minnesota School of Dentistry

机译:解决阿片类药物的疫情:明尼苏达大学牙科大学阿片类药物规定议定书的影响

获取原文
获取原文并翻译 | 示例

摘要

Prescription opioid medications continue to be abused on an epidemic level and have been shown to be a "gateway" drug to heroin abuse. Individuals experimenting with opioids commonly fall in the 10- to 19-year age range in which dentists are the highest preschbers. To reduce the number of excess opioids, the Department of Oral and Maxillofacial Surgery, University of Minnesota, developed and implemented an evidence-based opioid prescribing policy. Data were collected via electronic health record for the previous year and compared with the year following the protocol implementation. The results showed a drastic decrease (>46%) in the number of prescriptions given over a 1-year period. All departments reported a decrease in opioid prescriptions and the average number of tablets per prescription. The concern of undertreating pain was not found to be significant, as there was no increase in after-hours calls, recall appointments, or documentable emergency room visits. The results support the efficacy of an opioid prescribing policy's ability to lower the frequency and number of opioids given to patients, while still adequately treating patients' pain. Continued evaluation and modifications of the protocol and close monitoring of prescriber habits will enhance patients' pain control while also limiting the number of opioids available for abuse.
机译:处方阿片类药物继续滥用疫情水平,并且已被证明是海洛因滥用的“门户”药物。在牙医是最高的预期的10至19年的10年龄范围内,牙科医生通常落下的个人。为了减少多余的阿片类药物的数量,明尼苏达大学口腔颌面外科,制定并实施了一项以证据为基础的阿片类药物规定政策。通过前一年的电子健康纪录收集数据,并与协议实施后的一年进行比较。结果表明,在1年内给出的处方数量下降(> 46%)。所有部门报告称,阿片类药物处方和每处方药片的平均数量。未发现疼痛的关注是重要的,因为下班后呼叫,召回预约或可记录的急诊室访问没有增加。结果支持阿片类药物规定政策降低患者给予患者的阿片类药物数量的能力,同时仍然充分治疗患者的疼痛。持续的评估和修改方案和近期监测的终止监测将增强患者的疼痛控制,同时还限制了可用于滥用的阿片类药物的数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号